EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Vriddhadaru Rasayana in Mild Cognitive Impairment of Elderly: An Open Label Randomized Controlled Clinical Study

Ananyalakshmi E, Sowmyashree U P, Gopalakrishna G

Journal of Ayurveda and Integrated Medical Sciences · 05.05.2026 · 11 (4) · 58-65

DOI: 10.21760/jaims.11.4.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 05.05.2026. Verfasst von Ananyalakshmi E und 2 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mild Cognitive Impairment (MCI) is a neurological disorder characterized by slight but noticeable deficits in memory or other thinking skills with minimal impacts on daily functioning in older adults. It has been conceptualized as an intermediate phase between normal aging and dementia. The prevalence of MCI ranges approximately between 15-33% in India in 2019. Keeping in view the growing rate of MCI, this study was undertaken. Vriddhadaru Rasayana in Chakra Datta Rasayana Adhikara was taken as a trail drug to evaluate the efficacy of in management of MCI of elderly. Ashwagandha Root extract which is a proven drug for MCI is taken as control drug to compare and re-establish its efficacy levels. Materials and Methods: An open-label, parallel-group, randomized, controlled clinical study was conducted among 30 participants fulfilling the diagnostic and inclusion criteria for MCI were randomly assigned into 2 groups, Trial group and Control group comprising of 15 subjects each. Trial Group subjects received Vriddhadaru Rasayana and Control Group subjects received Ashwagandha root extract capsule for 30 days. The objectives of the study were to evaluate the efficacy of each intervention and compare the both, for which Score of MoCA Scale was used for assessment. The data obtained in both the groups were recorded, tabulated, and statistically analysed.

Results

Statistical analysis of the results within Trial Group showed statistically highly significant results and Within Control Group, statistically highly significant results in the score of MoCA Scale. Both the groups showed statistically highly significant results in the score of MoCA Scale.

Conclusion

The trial drug, Vriddhadaru Rasayana is more effective than the control drug Ashwagandha root extract capsule in the management of MCI of elderly.

Zitieren

APA

E, A., P, S. U., & G, G. (2026). Efficacy of Vriddhadaru Rasayana in Mild Cognitive Impairment of Elderly: An Open Label Randomized Controlled Clinical Study. Journal of Ayurveda and Integrated Medical Sciences, 11(4), 58-65. https://doi.org/10.21760/jaims.11.4.9

Vancouver

E A, P SU, G G. Efficacy of Vriddhadaru Rasayana in Mild Cognitive Impairment of Elderly: An Open Label Randomized Controlled Clinical Study. Journal of Ayurveda and Integrated Medical Sciences. 2026;11(4):58-65. doi:10.21760/jaims.11.4.9

BibTeX
@article{E2026,
  author = {E, Ananyalakshmi and P, Sowmyashree U and G, Gopalakrishna},
  title = {Efficacy of Vriddhadaru Rasayana in Mild Cognitive Impairment of Elderly: An Open Label Randomized Controlled Clinical Study},
  journal = {Journal of Ayurveda and Integrated Medical Sciences},
  year = {2026},
  volume = {11},
  number = {4},
  pages = {58--65},
  doi = {10.21760/jaims.11.4.9}
}
Kostenlos starten →